How should I manage a pregnant woman with low TSH?

Management of Low TSH in Pregnancy

If you are pregnant with a suppressed TSH, the immediate priority is to determine whether you have hyperthyroidism requiring treatment or gestational transient thyrotoxicosis that needs only observation—measure free T4 and free T3 now, and if elevated, start propylthiouracil immediately to prevent maternal heart failure, preterm delivery, and low birth weight. 1, 2, 3

Diagnostic Algorithm

Step 1: Confirm Hyperthyroidism vs. Gestational Transient Thyrotoxicosis

• Measure TSH, free T4, and free T3 to distinguish true hyperthyroidism from gestational transient thyrotoxicosis 4, 5
• Gestational transient thyrotoxicosis presents with suppressed TSH but free T4/T3 in the high-normal or mildly elevated range, typically accompanied by hyperemesis gravidarum in the first trimester 1, 3
• Graves' disease shows suppressed TSH with clearly elevated free T4 and often elevated free T3 2, 3
• Check TSH receptor antibodies (TRAb) if Graves' disease is suspected—positive antibodies confirm the diagnosis and predict risk of fetal thyrotoxicosis 4

Step 2: Determine Gestational Age

• First trimester (weeks 0-13): Propylthiouracil (PTU) is the mandatory first-line agent because methimazole causes severe congenital malformations including aplasia cutis, choanal atresia, and esophageal atresia 1, 2, 4
• Second and third trimesters (weeks 14-40): Switch from PTU to methimazole to minimize maternal hepatotoxicity risk, which can be severe and even fatal with PTU 1, 6, 5

Treatment Strategy for Confirmed Hyperthyroidism

Pharmacologic Management

Start propylthiouracil immediately if in the first trimester:

• Initial dose: 100-150 mg three times daily (total 300-450 mg/day) 7
• Target: Maintain free T4 in the high-normal range (not mid-normal) using the lowest effective dose to avoid fetal hypothyroidism 1, 2, 4
• Monitor free T4 or free thyroxine index every 2-4 weeks during active titration 1, 2, 3
• Once stable, check TSH every trimester 1

Switch to methimazole after week 13:

• Transition dose: Methimazole 10-30 mg once daily (roughly 1:10 to 1:20 conversion from PTU) 2, 6
• Continue targeting high-normal free T4 with the same monitoring schedule 1, 2

Critical Safety Monitoring

Agranulocytosis (life-threatening):

• Instruct the patient to immediately report sore throat, fever, or any signs of infection 2, 6, 7
• Obtain complete blood count (CBC) emergently if these symptoms develop and stop the thioamide immediately if agranulocytosis is confirmed 1, 2

Hepatotoxicity (especially with PTU):

• Monitor for fatigue, nausea, anorexia, jaundice, or right upper quadrant pain 7
• PTU carries higher hepatotoxicity risk, particularly at doses ≥300 mg/day, but can occur even at 50 mg/day 7, 5

Vasculitis:

• Watch for new rash, hematuria, decreased urine output, dyspnea, or hemoptysis 2, 6, 7

Adjunctive Symptom Control

• Beta-blockers (propranolol 20-40 mg three times daily) can temporarily control tremor, palpitations, and tachycardia until thioamide therapy lowers thyroid hormone levels 1, 2
• Discontinue beta-blockers once biochemical control is achieved to avoid fetal bradycardia 1

Management of Gestational Transient Thyrotoxicosis

Observation without antithyroid drugs is appropriate for most cases:

• This condition is self-limited and resolves by 14-18 weeks as hCG levels decline 1, 3
• Treat only if the patient has clear clinical signs of hyperthyroidism beyond hyperemesis (e.g., tachycardia >100 bpm at rest, tremor, heat intolerance, weight loss) 1
• If treatment is needed, use PTU with the same dosing and monitoring as for Graves' disease 4

Thyroid Storm (Medical Emergency)

Recognize the presentation:

• Fever, tachycardia disproportionate to fever, altered mental status (nervousness, restlessness, confusion, seizures), vomiting, diarrhea, and cardiac arrhythmias 1, 2

Immediate treatment protocol (do not wait for lab confirmation):

1. PTU or methimazole (loading dose: PTU 600-1000 mg, then 200-250 mg every 4 hours) 1, 2
2. Saturated solution of potassium iodide (SSKI) or sodium iodide (give at least 1 hour after thioamide to prevent worsening hyperthyroidism) 1, 2
3. Dexamethasone 2 mg IV every 6 hours 1, 2
4. Phenobarbital for sedation if needed 1
5. Supportive care: Oxygen, antipyretics (avoid aspirin—it displaces thyroid hormone from binding proteins), IV fluids, continuous monitoring 1, 2

Avoid delivery during thyroid storm unless absolutely necessary—maternal and fetal outcomes are significantly worse if delivery occurs during the crisis 1, 2

Surgical Management

Thyroidectomy is reserved for:

• Failure to achieve control with thioamides despite adequate dosing 1, 2
• Severe drug intolerance (agranulocytosis, marked hepatotoxicity) 1, 2
• Large compressive goiter causing airway compromise 2

Timing: Perform surgery in the second trimester (weeks 14-27) to minimize fetal risk 1, 2

Radioactive iodine (I-131) is absolutely contraindicated during pregnancy—it causes fetal thyroid ablation 1, 2, 7

Fetal and Neonatal Considerations

Monitor for fetal thyrotoxicosis if TRAb is positive:

• TSH receptor antibodies cross the placenta and can cause fetal hyperthyroidism 1, 8
• Check fetal heart rate and growth with ultrasound, nonstress testing, or biophysical profile depending on gestational age 1, 2

Inform the newborn's physician about maternal Graves' disease so appropriate neonatal thyroid monitoring can be arranged 1, 2

Transient neonatal thyroid suppression may occur with thioamide therapy but is usually self-limited and rarely requires treatment 2

Postpartum Management

Evaluate thyroid function 6 weeks after delivery:

• Postpartum thyroiditis occurs in 2-11.5% of women and can present with hyperthyroid or hypothyroid phases 1, 3
• Diagnose postpartum thyroiditis with new onset of abnormal TSH or free T4 levels after birth 1, 2

Breastfeeding is safe with both PTU and methimazole—only minimal amounts enter breast milk 1, 2, 7

Women who received I-131 must wait 4 months before breastfeeding 1, 2

Risks of Untreated or Inadequately Treated Hyperthyroidism

• Maternal: Severe preeclampsia, preterm delivery, heart failure, miscarriage 1, 2, 3
• Fetal/Neonatal: Low birth weight, stillbirth, fetal or neonatal hyperthyroidism 1, 6, 3

Common Pitfalls

• Failing to switch from PTU to methimazole after the first trimester increases maternal hepatotoxicity risk 1
• Targeting mid-normal or low-normal free T4 instead of high-normal increases risk of fetal hypothyroidism 1, 2, 4
• Using radioactive iodine during pregnancy causes irreversible fetal thyroid damage 1, 2
• Delaying treatment in confirmed Graves' disease leads to preventable maternal and fetal complications 1, 3